Chimera Investment (CIM)
(Delayed Data from NYSE)
$15.28 USD
+0.12 (0.79%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $15.27 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$15.28 USD
+0.12 (0.79%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $15.27 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Zacks News
Chimera (CIM) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Chimera (CIM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Chimera Investment (CIM) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of 45.95% and 39.33%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Chimera (CIM) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
While securitizations in the prior quarters are likely to have provided stable interest income for Chimera (CIM) in Q2, a challenging backdrop for Agency securities is likely to have hurt valuations.
Annaly (NLY) Q2 Earnings Beat Estimates, NII & Book Value Dip
by Zacks Equity Research
Annaly's (NLY) second-quarter results reflect a rise in the average yield on interest-earning assets and financing costs, while book value erosion ail.
Chimera Investment (CIM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Invest in the Invesco KBW High Dividend Yield Financial ETF (KBWD)?
by Zacks Equity Research
Sector ETF report for KBWD
AGNC Investment (AGNC) Beats on Q2 Net Spread and Dollar Roll
by Zacks Equity Research
While higher prepayments and a decline in asset yields hinder AGNC Investment's (AGNC) Q2 results, expansion in net interest spread has been a positive.
Top Ranked Income Stocks to Buy for June 22nd
by Zacks Equity Research
CIM, XOM, NAVI, and LCNB made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 22, 2021
Zacks Industry Outlook Highlights: Annaly Capital Management, Chimera Investment Corp and Granite Point Mortgage Trust
by Zacks Equity Research
Zacks Industry Outlook Highlights: Annaly Capital Management, Chimera Investment Corp and Granite Point Mortgage Trust
3 Promising mREIT Stocks to Buy From the Prospering Industry
by Devyani Chamria
With the Fed's continued support and favorable backdrop for credit market, Zacks REIT and Equity Trust industry players like NLY, CIM and GPMT are poised to enjoy near-term benefits.
Here's Why You Should Hold on to AGNC Investment (AGNC) Stock Now
by Zacks Equity Research
While AGNC Investment's (AGNC) prudent asset-selection efforts offer greater stability of cash flows, high prepayment speed continues to hinder its performance.
Chimera Investment (CIM) Is Up 1.77% in One Week: What You Should Know
by Zacks Equity Research
Does Chimera Investment (CIM) have what it takes to be a top stock pick for momentum investors? Let's find out.
Chimera Investment (CIM) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of 16.13% and 12.83%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chimera Investment (CIM) Enters Overbought Territory: Is A Drop Coming?
by Zacks Equity Research
Chimera Investment (CIM) has moved higher as of late, but there could definitely be trouble on the horizon for this company
Chimera Investment (CIM) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of -9.38% and -5.80%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chimera Investment (CIM) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of 6.45% and 11.93%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Here's How Chimera (CIM) Looks Just Ahead of Q3 Earnings
by Zacks Equity Research
Low LIBOR rates during the third quarter are likely to lead to have reduced interest income for Chimera's (CIM) floating-rate investments.
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Ranked Income Stocks to Buy for October 5th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, October 5th
Here's Why AGNC Investment Deserves a Place in Your Portfolio
by Zacks Equity Research
Timely changes in investment portfolio amid the ongoing Agency market-recovery phase and a strong financial position make AGNC Investment (AGNC) a compelling investment option.
Chimera (CIM) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Chimera (CIM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Factors Influencing Chimera's (CIM) Fate this Earnings Season
by Zacks Equity Research
Chimera's (CIM) Q2 NII results are expected to reflect the impacts of the loss of interest income earned on its Agency residential mortgage-backed investment due to the sale of the portfolio in Q1.
Chimera Investment (CIM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Chimera Investment (CIM) closed the most recent trading day at $9.16, moving +0.88% from the previous trading session.